Peroxisomal proliferator-activated receptor-γ upregulates glucokinase gene expression in β-cells

被引:78
作者
Kim, HI
Cha, JY
Kim, SY
Kim, JW
Roh, KJ
Seong, JK
Lee, NT
Choi, KY
Kim, KS
Ahn, YH
机构
[1] Yonsei Univ, Coll Med,Inst Genet Sci, Dept Biochem & Mol Biol, Seodaemoon Gu, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Med Res Ctr, Dept Lab Anim Med, Seoul, South Korea
[3] Korea Mil Acad, Dept Chem, Seoul, South Korea
关键词
D O I
10.2337/diabetes.51.3.676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thiazolidinediones, synthetic ligands of peroxisomal proliferator-activated receptor-gamma (PPAR-gamma), improve peripheral insulin sensitivity and glucose-stimulated insulin secretion in pancreatic beta-cells. To explore the role of PPAR-gamma in glucose sensing of beta-cells, we have dissected the beta-cell-specific glucokinase (PGK) promoter, which constitutes glucose-sensing apparatus in pancreatic beta-cells, and identified a peroxisomal proliferator response element (PPRE) in the promoter. The betaGK-PPRE is located in the region between +47 and +68 bp. PPAR-gamma/retinoid X receptor-alpha heterodimer binds to the element and activates the PGK promoter. The PGK promoter lacking or having mutations in PPRE cannot be activated by PPAR-gamma. PPAR-gamma activates the PGK promoter in beta-cells as well as non-beta-cells. Furthermore, troglitazone increases endogenous GK expression and its enzyme activity in beta-cell. Lines. These results indicate that PPAR-gamma can regulate GK expression in beta-cells. Taking these results together with our previous work, we conclude that PPAR-gamma regulates gene expression of glucose-sensing apparatus and thereby improves glucose-sensing ability of beta-cells, contributing to the restoration of beta-cell function in type 2 diabetic subjects by troglitazone.
引用
收藏
页码:676 / 685
页数:10
相关论文
共 36 条
[1]   ESTABLISHMENT OF 2-MERCAPTOETHANOL-DEPENDENT DIFFERENTIATED INSULIN-SECRETING CELL-LINES [J].
ASFARI, M ;
JANJIC, D ;
MEDA, P ;
LI, GD ;
HALBAN, PA ;
WOLLHEIM, CB .
ENDOCRINOLOGY, 1992, 130 (01) :167-178
[2]   Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J].
Barroso, I ;
Gurnell, M ;
Crowley, VEF ;
Agostini, M ;
Schwabe, JW ;
Soos, MA ;
Maslen, GL ;
Williams, TDM ;
Lewis, H ;
Schafer, AJ ;
Chatterjee, VKK ;
O'Rahilly, S .
NATURE, 1999, 402 (6764) :880-883
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance [J].
Cavaghan, MK ;
Ehrmann, DA ;
Byrne, MM ;
Polonsky, KS .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :530-537
[5]   THE TRIUMVIRATE - BETA-CELL, MUSCLE, LIVER - A COLLUSION RESPONSIBLE FOR NIDDM [J].
DEFRONZO, RA .
DIABETES, 1988, 37 (06) :667-687
[6]   GLUCOSE AFFECTS INVITRO MATURATION OF FETAL-RAT ISLETS [J].
DUDEK, RW ;
KAWABE, T ;
BRINN, JE ;
OBRIEN, K ;
POOLE, MC ;
MORGAN, CR .
ENDOCRINOLOGY, 1984, 114 (02) :582-587
[7]   Glucose-induced toxicity in insulin-producing pituitary cells that coexpress GLUT2 and glucokinase - Implications for metabolic engineering [J].
Faradji, RN ;
Havari, E ;
Chen, Q ;
Gray, J ;
Tornheim, K ;
Corkey, BE ;
Mulligan, RC ;
Lipes, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (39) :36695-36702
[8]   Cyclic adenosine 3′,5′-monophosphate increases pancreatic glucokinase activity and gene expression [J].
Fernandez-Mejia, C ;
Vega-Allende, J ;
Rojas-Ochoa, A ;
Rodriguez-Dorantes, M ;
Romero-Navarro, G ;
Matschinsky, FM ;
Wang, JH ;
German, MS .
ENDOCRINOLOGY, 2001, 142 (04) :1448-1452
[9]   CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS [J].
FUJIWARA, T ;
YOSHIOKA, S ;
YOSHIOKA, T ;
USHIYAMA, I ;
HORIKOSHI, H .
DIABETES, 1988, 37 (11) :1549-1558
[10]   In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression [J].
Harmon, JS ;
Gleason, CE ;
Tanaka, Y ;
Oseid, EA ;
Hunter-Berger, KK ;
Robertson, RP .
DIABETES, 1999, 48 (10) :1995-2000